AstraZeneca has agreed to acquire CinCor Pharma in a deal that could exceed $1 billion. CinCor Pharma develops treatments for resistant hypertension and chronic kidney disease,...
AstraZeneca will make a first payment of $200 million and another of $120 million in consideration, for Neogene Therapeutics. AstraZeneca is building a portfolio of cell...